JANUARY 14
  • SYMPOSIUM

    13th International
    symposium on MPS and
    related diseases

    2014.08.05 ~ 09 Bahia, Brazil
  • SYMPOSIUM

    13th International
    symposium on MPS and
    related diseases

    2014.08.05 ~ 09 Bahia, Brazil
  • SYMPOSIUM

    13th International
    symposium on MPS and
    related diseases

    2014.08.05 ~ 09 Bahia, Brazil
  • SYMPOSIUM

    13th International
    symposium on MPS and
    related diseases

    2014.08.05 ~ 09 Bahia, Brazil
  1. 세포가 있는 이미지
    자세히 보기
    Lipid nanoparticle for mRNA delivery

    To deliver mRNA into target cells in the body, a carrier is required. MOGAM is conducting research geared toward increasing the transfer efficiency of mRNA to target cells, and lowering the toxicity using various nanoparticles.

    자세히 보기
    mRNA design

    Through protein and mRNA engineering strategies, MOGAM is working on developing better therapeutics with improved efficiency and stability.

    Platform Technology

    mRNA /
    Nanoparticle

  2. 세포가 있는 이미지
    자세히 보기
    Antibody screening system

    Antibodies can be effectively generated through a B cell library using human and mouse immune responses and a synthetic library of various antibody formats.

    자세히 보기
    Hyper-stable single domain antibody

    MOGAM developed hyper-stable VH domain antibody similar to the IgG level using own protein engineering & screening system.

    Platform Technology

    Protein
    Engineering

M0GAM'S
IDENTITY & VISION
Identity
MOGAM'S IDENTITY & VISION
Helping
patients and
society
by developing new

treatments
Generating value with science
and open innovation
  1. Challenges in developing drugs for Rare Disorders MOGAM hopes that mRNA therapy will ease the physical, financial and psychological burdens on patients with rare diseases and their families.
  2. MOGAM works to unravel the fundamental
    and important pathways of immune mediated
    inflammatory disease
    Many immune cells communicate and collaborate with each other or with other cells in tissues to activate an immune response or inflammation.
  3. Infectious diseases are disorders caused by
    pathogenic microorganisms, such as bacteria, fungi, parasites, or viruses
    A numerous variety of microorganisms are found nearly everywhere in our environment. Although they are normally harmless or even helpful, some microorganisms called pathogens can cause diverse infectious diseases, including chickenpox, flu, herpes zoster, ...
  4. Our Oncology A key obstacle against the success of anti-cancer drugs is unwanted adverse effects. To overcome such problems, molecular-targeted drugs have been developed, which specifically attack growth factor receptors or signaling effectors that are dysregulated in cancer.